Fidelis Capital Partners LLC Has $3.77 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Fidelis Capital Partners LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 30.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,169 shares of the healthcare conglomerate’s stock after buying an additional 1,669 shares during the period. UnitedHealth Group accounts for 0.8% of Fidelis Capital Partners LLC’s holdings, making the stock its 23rd biggest holding. Fidelis Capital Partners LLC’s holdings in UnitedHealth Group were worth $3,774,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of UNH. Robbins Farley bought a new stake in UnitedHealth Group in the third quarter valued at $25,000. Richelieu Gestion SA bought a new stake in UnitedHealth Group in the fourth quarter valued at $26,000. CGC Financial Services LLC increased its stake in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC grew its holdings in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA grew its holdings in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 3.0 %

Shares of UnitedHealth Group stock traded up $14.17 during trading on Thursday, reaching $493.16. The company’s stock had a trading volume of 8,879,564 shares, compared to its average volume of 4,525,576. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a market cap of $454.66 billion, a price-to-earnings ratio of 30.38, a PEG ratio of 1.28 and a beta of 0.54. The firm’s 50-day moving average is $489.51 and its two-hundred day moving average is $515.38. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.26 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.75 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s payout ratio is currently 45.97%.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Piper Sandler boosted their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday. Bank of America reiterated a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Oppenheimer reissued an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Barclays upped their target price on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday. Three investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $569.68.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.